Abstracts


A 001 Gorter RW, Stein J, Stoss M, Schuler C: Phase II study to document anti-HIV efficacy of Iscador QuFrF (Viscum album L.). Workshop, Europäische Akademie Nonnweiler/Trier, AIDS-Forum, 2.-3. Februar 1996
   
A 002 Gorter RW: Prospektive, longitudinale Phase-III-Studie zur Bestimmung der präventiven und krebshemmenden Wirkung von Iscador Qu Spezial bei Patientinnen mit Cervixdysplasien. Workshop “Unkonventionelle medizinische Richtungen und unkonventionelle Methoden der Krebs­bekämpfung”, Bad Honnef, 23.-24. Februar 1996, Forschende Komplementärmedizin 1996, 4 (1): 66
   
A 003 v. Wely M, Stoss M, Gorter RW: Open-label phase II trial to document immunomodulating and anti-HIV activities of Iscador QuFrF in HIV-posi­tives. Second European Conference on Experimental AIDS Research, Stockholm, Sweden, May 31-June 3, 1997, Abstract book: 190-P4
   

A 004
 

 

v. Wely M, Stoss M, Gorter RW: Open-label Phase-II-Studie zur Bestimmung der immunmodulierenden und antiviralen Wirkungen von Iscador QuFrF bei HIV-positiven Patienten. Akademische Forschung in der anthroposophischen Medizin, Dornach 13.-15. Juni 1997, Der Merkurstab, Sonderheft Juni 1997: 31
   
A 005 Gorter RW, Schnelle M, Stoss M, v. Wely M: Cannabis and wasting in AIDS and cancer. 1997 Symposium on the Cannabinoids. International Cannabinoid Research Society (ICRS), Stone Mountain, Georgia, June 20-22, 1997, Abstract book: 87
   
A 006 Gorter RW: Cannabis und chronische Schmerzen. Der Deutsche Schmerztag 1998. 9. Deutscher interdisziplinärer Schmerzkongreß. Frankfurt a. M., 4.-8. März 1998, Abstractband: 26-27
   
A 007 Gorter RW, Rotty J, Heinzerling L, Schnelle M: The immunomodulating activities of Iscador Qu special (Viscum album) in patients with HPV-associated cervical dysplasia. 1 st Scientific Conference, Zakopane, March 5-8, 1998, Abstract book: 217
   
A 008 Gorter RW, Stoss M, Peter E, Soto Vera D: Prospective, open-label phase-II-study to document the immunomodulatory and anti-HIV-activity of Va QuFrF in HIV-positives over 11 months. 7. Deutscher AIDS-Kongreß, Essen, 2.-6. Juni 1999, European Journal of Medical Research 4 (Suppl I): 10
   
A 009 Strasser F, Schnelle M, Kuechler T, Reif M, Cerny T: How to study patients with cancer anorexia/cachexia syndrome (CCS): "work in progress report" from a placebo-controlled phase III trial with emphasis on the difficulties to define an adequate patient population and on the development of outcome measurement instruments. 1. Kongress des Research Network der European Association for Palliative Care, Berlin 7.-9. Dezember 2000, J Pain Sympt Managem 29 (6): S66
   
A 010 Cerny T, Lueftner D, Possinger K, Ernst G, Ruhstaller T, Meissner M, Ko YD, Schnelle M, Reif M, Strasser F: Oral cannabis-extract (CE) versus delta-9-tetrahydrocannabinol (THC) for patients with cancer-related anorexia (CRA): A randomized, double-blind, placebo-controlled multi­center study. 39 th Annual Meeting of the American Society for Clinical Oncology (ASCO), Chicago, May 31-June 3, 2003, Abstract # 101798
   
A 011 Büssing A, Stein GM, Bischof M, Hatzmann W, Bartsch F, Soto-Vera D, Fronk EM, Gmeindl M: Prevention of surgery induced depression of granulocyte function by intravenous application of a viscotoxin-containing extract from Viscum album L. 12. AEK Cancer Congress (Arbeitsgemeinschaft Experimentelle Krebsforschung), Würzburg, 25.-28. März 2003, Abstractband: 167
   
A 012 Kröz M, Zerm R, Laue HB von, Brauer D, Reif M, Heckmann C, Girke M: Regulationsverlust internistischer Patienten gemessen mit einem neuen Fragebogen zur endogenen Regulation. 109. Jahrestagung der DGIM (Deutsche Gesellschaft für Innere Medizin), Wiesbaden, 26.-30. April 2003, Medizinische Klinik 98, Abstractband
   
A 013 Wispler M, Kappler M, Soto Vera D, Reif M, Schnelle M, Zänker KS: Prospektive, randomisierte, teilkontrollierte Studie zur Aktivierung des Homings und des allgemeinen Aktivitätsniveaus von T-Lymphozyten durch subkutane Mistel-Extrakt-Injektionen bei gesunden männlichen Probanden. 3. Mistelsymposium Nonnweiler, 20.–22. November 2003, Abstractband: 18
   
A 014 Büssing A, Bischof M, Hatzmann W, Bartzsch F, Soto Vera D, Fronk EM, Gmeindl M, Stein GM: Hemmung der operations-assoziierten Depression der Granulozytenfunktion durch eine einmalige peri-operative intra­venöse Applikation eines Viscum Album L.-Extraktes. 3. Mistel­symposium Nonnweiler, 20.–22. November 2003, Abstractband: 23
   
A 015 Helwig S, Fronk ES, Reif M, Schnelle M, Hoffmann J: Maximally tolerated dose (MTD) of standardized cannabis extract in palliative cancer patients: preliminary results from an open-label, non-randomized phase I/II trial. International Association for Cannabis as Mecicine (IACM) 2 nd conference on Cannabinoids in Medicine, Köln, 12.-13 September 2003, http://www.acmed.org/german/nav/home-conference.htm : Cologne 2003, Reader, p. 21
   
A 016 Kröz M, von Laue H, Zerm R, Reif M, Gierke M, Heckmann C: A new long version of trait marker questionaire for endogenous regulation.; Program & Abstracts, 1 st World Congress of Chronobiologie. Sapporo, 2003, pp 73
   
A 017 Ernst G, Denke C, Reif M, Schnelle M, Hagmeister H: Standardized cannabis extract in the treatment of postherpetic neuralgia – a randomized, double-blind, placebo-controlled cross-over study. World Congress on Pain, Sydney, 21.- 26. August 2005
   
A 018

Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM: Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of delta-9-tetrahydrocannabinol (THC) after oral application of THC vs. standardized cannabis extract. International Association for Cannabis as Medicine (IACM) 3 rd conference on Cannabinoids in Medicine, Leiden, 9.- 10. September 2005, http://www.acmed.org./german/nav/home-conference.htm , Leiden 2005

   
A 019

Strasser F, Lueftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko Y-D, Schnelle M, Reif M, Cerny T: Oral Cannabis-Extract (CE) Versus Delta-9-Tetrahydrocannabinol (THC) For Patients with Cancer-Related Anorexia (CRA): A Randomized, Double Blind, Placebo-Controlled, Multicenter Study. International Association für

   
A 020

Kröz M, Kuhnert N, Brauer D, von Laue HB, Bockelbrink A, Reif M, Heckmann C, Girke M: Cancer Fatigue und gestörte Ruhe/Aktivitätsregulation bei rezidivfreien Mammakarzinom Patientinnen, Ergebnisse einer prospektiven Studie. Abstracts des 114. Internistenkongresses 2008 , Medizinische Klinik, Vol. 103, Suppl. 1: 192

   
A 021

Reif M, Kröz M, Schad F, von Laue HB, Feder G, Matthes H, Girke M: Classification procedure of the German version of the Cancer Fatigue Scale (CFS-D). Abstract ASCO Annual Meeting 2009, J Clin Oncol 27, 2009 (supl; abstr e20608)

   
A 022

Kröz M, Büssing A, von Laue HB, Reif M, Feder G, Schad F, Girke M, Matthes H: Reliability and validity of a new scale on internal coherence (ICS) of cancer patients. Abstract in Health and Quality of Life Outcomes 2009, 7:59

   
A 023
 

Gorter RW: Viscum album L. (aqueous extract) as an immunomodulator and antiviral drug in HIV. A Phase II Trial. Abstract 12th World AIDS Conference Geneva 28. Juni-3. Juli 1998

   
A 024 Schnelle, M: Cannabis as Medicine. Abstract Symposium about Industrial Hemp at the Swedish University of Agricultural Sciences, Alnarp, 30. August 2001, 25:29
   
A 025
 
Zajicek J, Reif M, Schnelle M, on behalf of the UK MUSEC Study Investigators:
Cannabis extract in the treatment of muscle stiffness and other symptoms in multiple sclerosis – results of the MUSEC study. Abstract ECTRIMS, 25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis, September 9-12, 2009, Düsseldorf, Germany
   
A 026 Kanitz J L, Pretzer K, Reif M, Witt K, Reulecke S, Voss A, Längler A, Henze G, Seifert G: The impact of eurythmy therapy on fatigue in healthy adults – A controlled trial. Abstract in European Journal of Intrgrative Medicine , Vol. 4, Issue 3, 2012, Pages e289-e297
   
A 027 Kanitz J L, Reif M, Rihs C, Krause I, Seeger K, Seifert G: Improvements of Well-being after one Single Rhytmical Massage Intervention in Stressed Adults – a Prospective, Randomised, Three Armed Study. Abstract in European Journal of Integrative Medicine , Vol. 4, suppl. 1, 2012: OP-163
   
A 028 Krötz M, Zerm R, Reif M, Broder von Laue H, Zander A, Schad F, Brinkhaus B, Matthes H, Girke M: Are autonomic  regulation (aR) and self-regulation predictors for internal coherence and distress in internal medicine patients? Abstract in European Journal of Integrative Medicine, Vol. 4, suppl. 1, 2012: OP-252
   
A 029 Galun D, Tröger W, Reif M, Schumann A, Stancović N, Milićević M: Phase III trial on mistletoe extract versus no antineoplastic therapy in patients with locally advanced or metastatic pancreatic cancer. Abstract in European Journal of Integrative Medicine, Vol. 4, suppl. 1, 2012: OP-007
   
A 030 Cesari M, Longhi A, Ferrari S, Reif M: Viscum album fermantatum pini versus oral etoposide as adjuvant treatment in osteosarcoma patients after second relapse. Abstract in European Journal of Integrative Medicine, Vol. 4, suppl. 1, 2012: OP-008
   
A 031 Kröz M, Zerm R, Reif M, von Laue H B, Schad F, Matthes H, Brinkhaus B, Girke M: Autonomic regulation – a psychometric concept for the measurement of hygiogeneseis. Abstract in Research in Complementary Medicine, Vol. 20, suppl. 3, 2013: OP-210
   
A 032 Kröz M, Reif M, Zerm R, Winter K C, Candir F, Quetz M, Brinkhaus B, Girke M, Gutenbrunner C: The concept of a new multimodal approach based on Anthroposophic  Medicine in the treatment of chronic cancer-related-fatigue in breast cancer patients. Abstact in Research in Complementary Medicine, Vol. 20, suppl. 3, 2013: OP-211
   
A 033
 
Reif M: Kohortenstudien als Grundlage für erweiterte Erkenntnisse der Wirksamkeit pflanzlicher Präparate am Beispiel der Mistel. Abstract in Evidence-based Medicine und pragmatische Forschung in der Phytotherapie 28. Schweizerische Tagung für Phytotherapie, Baden 21. November 2013
   
A 034
 
Tröger W, Reif M Galun D, Schumann A, Stancović N, Milićević M: Viscum album [L.] Extract-Therapie versus keine antineoplastische Therapie bei Patienten in lokal fortgeschrittenem oder metastasiertem Stadium des Pankreas-Karzinoms: Eine randomisierte konfirmative klinische Studie. ASORS Kongress 2013
   
A 035
 
Galun D, Tröger W, Reif M, Schumann A, Stancović N, Milićević M: Viscum album [L.] extract therapy versus no antineoplastic therapy in patients with locally advanced or metastatic pancreatic cancer: a randomized confirmatory clinical trial (ISRCTN 70760582). 10th E-AHPBA 2013
   
A 036
 
Tröger W, Reif M, Galun D, Schumann A, Stancović N, Milićević M: Viscum album [L.] extract therapy versus no antineoplastic therapy in patients with locally advanced or metastatic pancreatic cancer: a randomized confirmatory clinical trial (ISRCTN 70760582). MASCC 2013
   
A 037 Tröger W, Galun D, Reif M, Schumann A, Stancović N, Milićević M: Mistletoe Therapy For Patients With Advanced Pancreatic Cancer: Overall Survival And Quality Of Life. 7th ECIM, Belgrad, 10.-11. Oktober 2014
   
A 038 Kröz M, Reif M, Glinz A, Berger B, Nikolaou A, Zerm R, Brinkhaus B, Girke M, Büssing A, Gutenbrunner C: Multimodal and combined multimodal-aerobic therapy in breast survivors with cancer-related fatigue. Journal of Clinical Oncology, ASCO Annual Meeting 29.05.2015-02.06.2015
   
A 039 Kröz M, Didwiszus A, Gelin-Kröz B, Pranga D, Reif M, Brink F, Zerm R, Gutenbrunner C, Büssing A: Reliability of the inner correspondence and harmony questionnaire with painting therapy (ICPTh). European Journal of Integrative Medicine 8S; 1-66; 2016

 


Posters


P 001
 
Strasser F, Schnelle M, Kuechler T, Reif M, Cerny T: How to study patients with cancer anorexia/cachexia syndrome (CCS): "work in progress report" from a placebo-controlled phase III trial with emphasis on the difficulties to define an adequate patient population and on the development of outcome measurement instruments. 1. Kongress des Research Network der European Association for Palliative Care, Berlin 7.-9. Dezember 2000
   
P 002
 
Kröz M, Zerm R, Laue HB von, Brauer D, Reif M, Heckmann C, Girke M: Regulationsverlust internistischer Patienten gemessen mit einem neuen Fragebogen zur endogenen Regulation. 109. Jahrestagung der DGIM (Deutsche Gesellschaft für Innere Medizin), Wiesbaden, 26.-30. April 2003
   
P 003 Kröz M; Schneider A; Brauer D; Zerm R; Reif M; Kirchhoff M; von Laue HB; Girke, M: Reliabilität und Validität der deutschen Version der Cancer Fatigue Scale (CFS-D). 110. Jahrestagung der DGIM (Deutsche Gesellschaft für Innere Medizin), Wiesbaden, 17.–21.April 2004
   
P 004 Kröz M; Reif M; Zerm M; von Laue B; Brauer D; Heckmann C; Debus M; Bartsch C: Results of a discrimination analysis between patients with breast- and colon carcinoma. 27. Deutscher Krebskongress, Berlin 22.-26. März 2006
   
P 005
 
Ernst G; Denke C; Reif M; Schnelle M; Hagmeister H: Standardized Cannabis Extract in the treatment of postzosteric neuralgia- a randomized, double-blind, placebo-controlled cross-over study. World congress on Pain, Sydney 21.-26. August 2005
   
P 006 Holdcroft A; Maze M; Tebbs S; Doré C: An Escalating Dose Study of cannador for postoperativce pain: Dose related effects. Studie 21-05(CANPOP), IACM 2 nd Conference on Cannabinoids in Medicine, Köln 12.-13. September 2003
   
P 007 Kröz M, Feder G, Brauer D, Von Laue H.B, Reif M, Girke M, Riess O.H, Zerm F, Schad F: Reliability, Validity and Mistletoe Sensitivity of the German Version of the Cancer Fatigue Scale (CFS-D). 4th Mistletoe Symposium, 15. Oktober 2007, Phytomedicine 14 (2): S33
   
P 008 Kröz M, Reif M, Debus M, Girke M, Humbroich K, Von Laue H.B, Brauer D: Validation of a New Scale on Internal Coherence (ICS) with Mistletoe-Sensitive Questions for Cancer Patients. 4th Mistletoe Symposium, 15. Oktober 2007, Phytomedicine 14 (2); S53
   
P 009 Büssing A, Bückner U, Enser-Weis U, Schnelle M, Schumann A, Schietzel M, Hatzmann W, Hackmann J: Randomisierte Phase-II-Studie zur Modulation einer chemotherapiebedingten Immunsuppression durch Mistelextrakt-Infusionen. Poster zur Studie 23-01, Wissenschaftstage 2007 an der Uni Witten/ Herdecke, 01.-02. Juni 2007“
   
P 010
 
Zajicek J, Reif M, Schnelle M on behalf of the MUSEC study investigators: Cannabis extract in the treatment of muscle stiffness and other symptoms in multiple sclerosis – results of the MUSEC study. Poster ECTRIMS, 25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis, September 9-12, 2009, Düsseldorf, Germany
   
P 011
 
Galun D, Tröger W, Reif M, Schumann A, Stancović N, Milićević M: Mistletoe extract therapy versus no antineoplastic therapy in patients with locally advanced or metastatic pancreatic cancer: a randomized clinical phase III trial on overall survival. Annals of Oncology, Vol. 23, suppl. 9, 2012, 9:712P
   
 

 

Contact

Please contact us, if you have any questions.
Mr Mrs. Company Name
Email
Telephone
Fax
Your Message
   

Please enter the security code.
 
© Website & Webdesign by Mosaic